Citation tools
"Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-estradiol positron emission tomography/computed tomography for the assessment of estrogen receptor status of recurrent or metastatic lesions in patients with breast cancer: an open label, non-randomized, phase 3 study." Journal of Nuclear Medicine
59.supplement 1
(2018):
487.
Web. 24 April. 2024.